Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists
Built on a new AI-native architecture, Concentriq delivers clinically and scientifically grounded intelligence to decisions throughout drug discovery, development, and case review PHILADELPHIA, June 17, 2026 (GLOBE NEWSWIRE) — Proscia® today introduced the Fifth Generation of its Concentriq®1 platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.